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Abstract 
BACKGROUND: Type 2 Diabetes Mellitus (T2DM) remains as a global public health problem, including Indonesia 
due to its continuous increasing prevalence.  
AIM: To analyze the impact of pharmacist intervention on drug-related problems (DRPs) occurred in the 
management of patients with T2DM admitted to Tebing Tinggi Hospital (TTH), Indonesia, period March through 
August 2018.  
METHODS: This six-month retrospective prospective cohort study evaluated the impact of pharmacist 
intervention on the occurrence of DRPs in the management of patients with T2DM (n = 45) insured by Social 
Security Organizing Body in TTH, North Sumatera, Indonesia. The inclusion criteria were T2DM patients with age 
≥ 18 years and under treatment of antidiabetic drugs. A questionnaire was used to assess the characteristics of 
the patients and antidiabetic drugs provided. The incidence of DRPs in groups with usual care for the previous 
three-month and with pharmacist interventions for the next three-month admissions were analyzed using 
Pharmaceutical Care Network Europe (PCNE) DRP classification system version 8.01 that consists of 3 primary 
domains for problems, 8 primary domains for causes, and 5 primary domains (PCNE, 2017) and trustable 
literatures. The obtained data were analyzed using descriptive statistics and paired t test in the program of 
Statistical Package for the Social Sciences version 19 (p < 0.05 was considered significant). 
RESULTS: Most (66.7%) of the patients were female. Their mean age was 61.96 ± 6.45 (years). The three most 
widely provided drugs were metformin, glimepirid, and gliclazide. Total incidence of DRPs in groups with: usual 
care, 128; intervention, 39. There was a significant difference between the incidence of DRPs in groups with usual 
care and intervention, p ≤ 0.001.  
CONCLUSION: Pharmacist intervention reduced the incidence of DRPs in the management of T2DM patients. 
 
 
 
 
 
Introduction 
 
Diabetes mellitus (DM) remains as a serious 
global public health threat that is growing rapidly in 
developed as well as developing countries, including 
Indonesia. Based on the World Health Organization 
(WHO) finding, the global prevalence of diabetes has 
increased from 4.7% in 1980 to 8.5% in 2014. A fact 
indicated that 1.5 million deaths occurred in 2012 due 
to diabetes. Globally, morbidity of DM patients was 
422 million adults in 2014 compared to108 million in 
1980 [1]. In Indonesia itself the morbidity of DM 
patients was 8.4 million in the year 2000 and was 
predicted to increase to 21.3 millions in 2030 [2]. 
Type 2 diabetes mellitus is a metabolic 
disorder due to insufficiency of insulin function marked 
by high blood glucose levels and followed by 
carbohydrates, lipids and proteins metabolism 
interference due to failure or insufficient insulin 
production by the beta cells of the pancreatic islets [1], 
[3]. Lifestyle of the Indonesian population has been 
affected by the advancement of economic 
development. This condition has reduced their 
physical activities causing changes in patterns of 
diseases [4]. In addition, socioeconomic levels, 
including education, employment, and marital status 
also promote the increasing prevalence of the disease 
[2]. 
There are numerous factors associated with 
the successfulness of the treatment of diabetes, 
including sufficient health services provided by 
healthcare providers and the adherence of the 
patients to their medications [5]. Patients with T2DM 
Nasution et al. Pharmacists Intervention Reduced Drug-Related Problems in the Treatment of Patients with Type 2 Diabetes Mellitus 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Nov 30; 7(22):3856-3860.  3857 
 
who do not adhere to their medications will in turn 
result in insufficient treatment, finally cause 
complications, including nephropathy which the risk 
for kidney disease, retinopathy with potential 
blindness, neuropathy causing nerve tissue damage, 
gastrointestinal symptoms, amputation, and 
impotency [2]. These conditions require complex 
management and multiple drug therapies which in turn 
tend to result in DRPs causing not only sub optimal 
therapeutic outcomes but also increase costs. These 
issues are the global challenges of the health care 
systems [6], [7]. The occurrence of DRPs in the 
management of diseases as well as T2DM may vary 
from one country to another. 
Management of T2DM should always be 
monitored and studied to avoid negative clinical 
outcomes. Thus, active participation of pharmacists to 
identify, to prevent, and to resolve the incidence of 
DRPs in the management of T2DM is crucial to 
optimize outcomes. A systematic review conducted on 
36 pharmacist intervention studies involving 5,761 
participants indicated greater varied outcomes in the 
intervention groups compared to the groups without 
the involvement of pharmacists [8]. Another 
systematic review on 59 pharmacy-led intervention 
studies on the management of T2DM also indicated 
the significant enhancement of the patients’ outcomes 
compared with usual care groups [9]. In contrast, a 
systematic review of randomized controlled trials and 
pre-post-test studies in the management of T2DM 
undertaken in South Asia revealed that there was only 
little improvement of the disease outcome in 
intervention groups compared with usual care [10]. 
There was a limited intervention study on DRPs in the 
management of T2DM patients undertaken in 
Indonesian health care facilities. 
In light of these issues, the present study 
aimed to analyze the impact of pharmacy intervention 
in the management of T2DM patients admitted to 
TTH, North Sumatera, Indonesia. 
 
 
Material and Methods 
 
This six-month prospective cohort study was 
conducted to evaluate the DRPs in the management 
of outpatients with T2DM (n = 45) insured by Social 
Security Organizing Body in TTH, North Sumatera, 
Indonesia period March through August 2018. Before 
conducting this study, ethical clearance was obtained 
from the Health Research Ethical Committee of North 
Sumatera, School of Medicine, University of Sumatera 
Utara, Medan, Indonesia. The inclusion criteria were 
patients diagnosed with T2DM, age ≥ 18 years, and 
under treatment of antidiabetic drugs.  
The researchers explained the study to each 
of the patients and set up the schedule for the data 
assessment. A self-designed questionnaire was used 
to assess the characteristics of the patients and 
antidiabetic drugs provided. The patients’ 
characteristics were descriptively analyzed. The 
PCNE version 8.01 instrument [11] and trustable 
literatures were used to analyze the incidence of 
DRPs in the management of the T2DM patients in 
groups with usual care for the previous three-month 
and pharmacist intervention for the next three-month 
patients’ admissions. The PCNE DRP classification 
system applied in this study is listed in Table 1. The 
significance of intervention was analyzed applying 
paired t test. All analyses were performed using 
Statistical Package for the Social Sciences (SPSS, 
version 19, Chicago, IL, USA) (p < 0.05 was 
considered significant). 
Table 1: The PCNE DRP classification system version 8.01 
 Code Primary domains 
Problems 
P1 
P2 
P3 
There is a problem with the effect of the pharmacotherapy 
Patient suffers from adverse drug event 
Others 
Causes 
C1 
C2 
C3 
C4 
C5 
C6 
C7 
C8 
Inappropriate drug selection 
Selection of inappropriate dosage form 
Inappropriate dosage selection 
Inappropriate duration of treatment 
The cause of DRP is related to prescribing and dispensing process 
The cause of DRP is related to the way patient gets the drug 
The cause of DRP is related to the patient and his behavior. 
Other 
Planned 
Intervention 
I0 
I1 
I2 
I3 
I4 
No intervention 
At prescriber level 
At patient level 
At drug level 
Other 
Acceptance 
A1 
A2 
A3 
Intervention accepted 
Intervention not accepted 
Other 
Status of 
DRP 
O0 
O1 
O1 
O3 
Problem unknown 
Problem solved 
Problem partially solved 
Problem not solved 
 
  
 
Results  
 
Characteristics of the T2DM patients 
Of the 130-target population, there were only 
45 T2DM patients fulfilled the inclusion criteria. Thus, 
these patients were included into this study. 
Characteristics of the T2DM patients according to 
gender, age, and education are demonstrated in 
Table 2. In the present study, there were more female 
(67%) admitted to the hospital compared to male 
(33%) during the study period. Most (56%) of the 
patients were in the age group of 60 years or above. 
Only 44% of the patients were in the age of younger 
than 60 years. Overall, the mean age of the patients 
was 61.96 with a standard deviation of 6.45 years.  
In terms of education, it was found, as shown 
in Table 2, that 17.8% and 15.6% of them graduated 
from primary school and Junior High School, 
respectively. As much as 28.9% of the patients 
graduated from senior high schools. It was found that 
more than one-third (37.8%) of the patients graduated 
from universities. 
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Table 2: Characteristics of the T2DM patients (n = 45) 
Variable Percentage (%) 
Gender: 
Male 
Female 
 
33 
67 
Age (years): 
< 60 
> 60 
 
44 
56 
Education: 
Primary school  
Junior High School 
Senior High School 
University 
 
17.8 
15.5 
28.9 
37.8 
 
Utilization of antidiabetic drugs 
The pattern of antidiabetic drugs provided to 
the T2DM patients in groups before and after 
education in decreasing order is listed in Table 3. 
During the six-month period of patients’ admission, as 
shown in Table 3, it was obtained that the four most 
widely prescribed antidiabetic drugs in both groups 
were metformin 500 mg, glimepiride 2 mg, gliclazide 
80 mg, and glimepiride 4 mg. 
Table 3: Pattern of antidiabetic drugs provided to the T2DM 
patients (n = 45) 
  
Usual care Intervention group 
Number of 
units 
Costs (in Rp) 
Number of 
units 
Costs (in Rp) 
Metformin 500 mg 1444 414.428 1672 479.864 
Glimepiride 2 mg 868 261.268 970 291.970 
Gliclazide 80mg 320 93.760 430 125.990 
Glimepiride 4 mg 130 50.050 272 104.270 
Acarbose 50 mg 104 72.280 0 0 
Glimepiride 3 mg 80 28.320 130 46.020 
Glimepiride 1 mg 50 12.850 90 23.130 
Apidra 46 4,802.354 37 3,862.763 
Lantus 14 1,326.000 20 2,040.000 
Humolog Mix 0 0 2 264.000 
  
The two most expensive antidiabetic drugs 
provided to the T2DM patients were apidra and lantus. 
In facts these two drugs were least frequently 
prescribed to the patients. 
 
Drug related problems 
The incidence of DRPs in the management of 
T2DM patients is shown in Table 4. It was found that 
44 incidences were related to diet and physical 
inactivity. The second highest incidence was that 39 
patients did not reach the target of blood glucose level 
(≤ 200 mg/dL) in the group with usual care indicating 
the occurrence of ineffective treatment. However, in 
the intervention group, as indicated in Table 4, the 
occurrence of ineffective treatment measured from 
blood glucose level decreased to only 20 (44%) of the 
patients.  
This study also revealed 6 cases with wrong 
dose timing instructions occurred in the group with 
usual care. Four patients took metformin before meals 
supposed to be provided after or at mealtime. One 
patient took acarbose before meal, while this drug has 
to be taken at meal time to reduce the absorption of 
simple carbohydrate in the GI tract. This study proved 
based on interview, one patient took glimepiride after 
meal, while this drug should be taken before meal. 
Table 4: Incidence of DRPs in the management of T2DM 
patients (n = 45) 
Primary domain Code Problem 
Usual 
care 
Intervention 
group 
Treatment 
effectiveness 
P1.2 
Effect of drug treatment not optimal 
(number of cases) 
39 20 
Dose selection 
C3.5 
Dose timing instructions wrong, 
unclear or missing (number of cases) 
6 0 
C5.2 
Necessary information not provided 
(number of cases) 
1 0 
C7.6 
Patients stored drug inappropriately 
(number of cases) 
1 0 
C7.7 
Inappropriate timing or dosing interval 
(number of cases) 
37 11 
C8.2 
Other: Diet and physical activity 
(number of cases) 
44 8 
  Total 128 39 
 
Another DRP identified in the group with usual 
care was one patient did not receive the necessary 
information from the health care provider regarding 
the storage of apidra, consequently the patient stored 
this medication inappropriately. This drug must be 
stored at temperature between 2-8°C to maintain its 
stability [12]. The later 2 cases were not obtained in 
the group with intervention. Additionally, as many as 
37 patients took their medications at inappropriate 
dosing intervals in the group with usual care. This 
DRP category reduced to 11 incidences in the group 
with intervention. This study also proved that 44 out of 
45 patients did not practice healthy diet and physical 
activity in the group with usual care, while this DRP 
has been decreased to 8 cases in the group with 
intervention. 
Overall, the number of incidences of DRPs in 
the group with usual care were 128 has been reduced 
to 39 in the group with intervention. The incidences of 
DRPs in the management of T2DM with pharmacist 
intervention reduced significantly compared those with 
usual care, p ≤ 0.001.  
 
 
Discussion 
 
The present study found that 66.7% of the 
patients were female. This finding supported similar 
studies undertaken in Indonesia and USA [13], [14], 
[15]. It was indicated that 56% of the T2DM patients 
were at the age of 60 years or above. Aging 
decreases the pancreatic β cell sensitivity to glucose 
and delay the mediation of glucose uptake by insulin 
into the cells [16]. The majority of the T2DM patients 
(62.2%) graduated only from senior high school and 
lower. This limited education may have an impact on a 
failure to understand the importance of adherence to 
prescribed medications [10]. 
With regard to antidiabetic utilization, this 
study indicated that metformin was the most 
frequently prescribed drug to the T2DM patients 
followed by glimepiride and gliclazide. Patterns of 
antidiabetic utilization vary widely depend on the 
medical condition of the patients, severity of the 
disease, and its complications [5]. 
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The occurrence of DRPs can result in failure 
to achieve the targeted blood glucose level in patients 
T2DM and increase in resource consumption [7]. 
Thus, identification of DRPs is important to improve 
effectiveness and efficiency in the management of 
T2DM. The present study revealed that the most 
frequently occurred problems in the treatment of 
T2DM with usual care were unhealthy diet and 
insufficient physical activity followed by treatment 
effectiveness and inappropriate drug dosing interval. 
The latter problem is related to the irregularity of 
patients’ visit to this secondary health center. The 
patients did not immediately visit the health centers 
when they ran out of their antidiabetic medications, 
missed doses for several days, which in turn 
decreased the treatment outcomes and developed 
complications. In the intervention group, these 
problems were significantly reduced. A study in 
Scandinavia proved that counseling through video 
conference conducted on T2DM patients had a 
positive attitude towards increasing physical activity 
[17]. 
This study indicated that pharmacist 
education significantly decreased the incidence of 
DRPs in management of T2DM patients. This result is 
consistent with the previous pharmacist intervention 
studies conducted in different countries. In 2016, 
Pousinho et al., conducted a systematic review on 36 
studies in the management of T2DM consisted of 
5,761 participants with and without pharmacist 
interventions. They proved that greater outcomes 
were obtained in the intervention groups compared to 
the groups with usual care [8]. More recent systematic 
review conducted by Presley et al., on 59 pharmacist 
intervention studies in the management of T2DM 
patients also indicated the significant increase in the 
patients’ outcomes compared with usual care groups 
[9]. However, Bhurji et al., revealed, in their 
systematic review of randomized controlled trials and 
pre-post-test studies in the management of T2DM 
undertaken in South Asia, that there was only little 
improvement of the disease outcome in intervention 
groups compared with pre-test or usual care groups 
[10]. 
In conclusions, involvement of pharmacists in 
the management of T2DM patients could decrease 
significantly the incidence of DRPs. These findings 
should be highlighted and considered by the policy 
makers to improve the management of T2DM 
patients.  
 
 
Study limitation 
 
This study is limited by the small number of 
T2DM patients involved in this study. 
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